| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 05/11/2006 | WO2006049232A1 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2006024387A3 Biphenyl-thiazolo-carboxamides |
| 05/11/2006 | US20060100256 Reacting bromine with an aqueous solution of 4-acetamidocyclohexanone to produce 2-bromo-4-acetamidocyclohexanone; adding thiourea to produce 6-acetylamino-2-amino-4,5,6,7-tetrahydrobenzothiazole; and cleaving the acetyl group with hydrobromic acid; forming pramipexole by reaction with a propionyl halide |
| 05/11/2006 | US20060100250 Biphenyl derivatives and their use as fungicides |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/10/2006 | EP1655291A1 Compounds having thrombopoietin receptor agonism |
| 05/10/2006 | EP1655287A1 Probe for diseases with amyloid accumulation, amyloid-staining agent, remedy and preventive for diseases with amyloid accumulation and diagnostic probe and staining agent for neurofibrillary change |
| 05/10/2006 | EP1654342A1 Reactions products of mercaptobenzothiazoles, mercaptothiazolines, and mercaptobenzimidazoles with epoxides as lubricant additives |
| 05/10/2006 | EP1654324A1 Sulphonamide anions as catalysts for nco oligomerisation |
| 05/10/2006 | EP1654213A1 Matrix metalloproteinase inhibitors |
| 05/10/2006 | EP1653954A1 Antibiotic thiazolidines |
| 05/10/2006 | EP1418911B1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 05/10/2006 | CN1771087A Method for preparing bisphenol catalysts and bisphenols |
| 05/10/2006 | CN1771057A Releasable polymeric conjugates based on biodegradable linkers |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | US7041354 Optical data carrier comprising a cyanine dye as light-absorbent compound in the information layer |
| 05/09/2006 | CA2257328C Thiazole derivatives |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006045639A1 Silane esters and amides of 2-oxothiazolidine-4-carboxylic acid, and cosmetic uses thereof |
| 05/04/2006 | WO2005086661A3 Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders |
| 05/04/2006 | US20060094882 Ambient-temperature molten salts and process for producing the same |
| 05/04/2006 | US20060094769 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis |
| 05/04/2006 | US20060094739 pharmaceutical drug for treating a fungal infection; controlling and preventing plant pathogenic microorganisms in agricultural crops |
| 05/04/2006 | US20060094718 O-substituted hydroxyaryl derivatives |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | US20060093852 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies |
| 05/04/2006 | CA2584465A1 Heterocyclic carbonyl compounds and their use as sgk-inhibitors |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2583271A1 Benzylthiazolone inhibitors of estrogen-related receptors (err) |
| 05/03/2006 | EP1652839A2 Drug efflux pump inhibitor |
| 05/03/2006 | EP1652837A1 Aminocarbonyl naphthol derivative, cyanonaphthol derivative, and method for producing them |
| 05/03/2006 | EP1651626A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 05/03/2006 | EP1651625A1 Pramipexole acid addition salts |
| 05/03/2006 | EP1651624A2 Process for the preparation of substituted thiazoles |
| 05/03/2006 | EP1495007A4 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses |
| 05/03/2006 | EP1364040B1 Degradation of epothilones and ethynyl substituted epothilones |
| 05/03/2006 | EP1280791B1 N-heteroarylmethyl-m-phenylenediamine derivative-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | CN1254468C Preparation method of carboxyalkyl lotanning |
| 05/02/2006 | US7038073 Synthesis of 2-alkyl amino acids |
| 05/02/2006 | US7037937 Cytotoxic compounds |
| 05/02/2006 | US7037930 3-arylphenyl sulfide derivative and insecticide and miticide |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037914 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/02/2006 | US7037880 Ethylene derivatives and pesticides containing said derivatives |
| 05/02/2006 | CA2174544C Method for using pharmaceutical compositions containing 2-(2-alkylphenylamino)-oxazolines, 2-(2-alkylphenyl-amino)-thiazolines and 2-(2-alkylphenylamino)-imidazolines as adrenergic agents |
| 04/27/2006 | WO2006045088A2 Polymer-filler coupling additives |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2006013445A3 Thiazolidinedione derivatives as alpha adrenergic receptor antagonists |
| 04/27/2006 | US20060089396 N-(5-Halo-2-thiazolyl)benzamides, e.g., 2-(acetoxy)-3-methyl-N-(5-bromo-2-thiazolyl)benzamide; antiviral agents that are more selective for viral pathogens, and accordingly cause reduced deleterious effects upon beneficial gut microflora when administered orally |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089371 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 04/27/2006 | US20060089366 New piperazine and piperidine compounds |
| 04/27/2006 | US20060089357 Novel compounds and compositions as cathepsin inhibitors |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | US20060089313 Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 04/27/2006 | DE102004051277A1 Heterocyclische Carbonylverbindungen Heterocyclic carbonyl |
| 04/27/2006 | CA2583784A1 Preparation and use of biphenyl-4-yl-carbonylamino acid derivatives for the treatment of obesity |
| 04/26/2006 | EP1650267A1 Monoazo compound and method for producing same |
| 04/26/2006 | EP1649871A1 Retroviral protease inhibitor combinations |
| 04/26/2006 | EP1648856A1 O-coordinated metal chelates and their use in optical recording media having high storage capacity |
| 04/26/2006 | EP1648564A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors |
| 04/26/2006 | EP1453817B1 Thiazole derivatives with fungicidal activity |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1763020A 3,3',5,5'-tetramethyl benzidine derivative and its preparation method and uses |
| 04/26/2006 | CN1762989A Semicarbazone synthesis method |
| 04/26/2006 | CN1253436C Large conjugated half cyanine dye, its synthesis and its sensitized nano-crystal semiconductor solar energy battery |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034046 NR1H4 nuclear receptor binding compounds |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/20/2006 | WO2006042195A1 Alkyl benzamides |
| 04/20/2006 | WO2006040281A1 Thiazolyl-dihydro indazoles |
| 04/20/2006 | WO2006040279A1 Pi3 kinases |
| 04/20/2006 | WO2006011631A3 Thiazole derivatives having vap-1 inhibitory activity |
| 04/20/2006 | WO2005096734A3 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084730 Having oxazole, thiazole, tri(alkoxy)silanes or triallyltin moieties connected by an arylene or alkylene linker moiety to a dipolar nitrone, nitrile oxide or nitrilimine moiety; rubbers with reduced hysteresis; tires |
| 04/20/2006 | US20060084689 Thiazole-amine compounds for the treatment of neurodegenerative disorders |
| 04/20/2006 | US20060084680 ((1S)-5-{2-[(3-methyl-7-propyl-1,2-benzisoxazol-6-yl)oxy]ethoxy}-2,3-dihydro-1H-inden-1-yl)acetic acid; diabetes, obesity, hyperlipidemia, and atherosclerotic diseases; hyperglycemia, hyperinsulinemia, impaired glucose tolerance, dyslipidemia, hypertriglyceridemia, and insulin resistance |
| 04/20/2006 | US20060084663 Alkanoic acids, nitriles and amides substituted with a group containing benzene ring linked through a thiazolyl- or oxazolyl- phenyl group; e.g., {4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethylsulfanyl]-2-propyl-phenoxy}-acetic acid; treating diabetes and atherosclerosis |
| 04/20/2006 | US20060084658 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
| 04/20/2006 | US20060084657 Piperazine derivative |
| 04/20/2006 | US20060084576 Hetaryl substituted homotetramic and homotetronic acids and their use thereof as pesticides |
| 04/20/2006 | US20060083677 Solid-phase fluorination of benzothiazoles |
| 04/20/2006 | CA2579288A1 Thiazolyldihydroindazoles |
| 04/20/2006 | CA2579279A1 Tricyclic thiazole derivatives as pi3 kinases |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1646383A1 Design and synthesis of optimized ligands for ppar |
| 04/19/2006 | EP1423363B1 Oral antidiabetic agents |
| 04/19/2006 | EP1420784B1 Compounds effecting glucokinase |
| 04/19/2006 | EP1383729A4 Peptide deformylase inhibitors |